The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correction to Lepor et al., N Engl J Med 335(8):533-540 August 22, 1996.

Correspondence
PreviousPrevious
Volume 336:293-294 January 23, 1997 Number 4
NextNext

Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
by Lepor, H.
-Related Article
by Lepor, H.
-PubMed Citation
To the Editor: The study by Lepor et al. (Aug. 22 issue)1 confirms the efficacy of {alpha}1-adrenergic antagonists in the management of benign prostatic hyperplasia. It also underscores the importance of focusing on the patients' symptoms, rather than relying on proxy physiologic measurements that correlate variably with the symptoms.2,3 However, although the American Urological Association Symptom Index includes both "irritative" symptoms (frequency, urgency, and nocturia) and "obstructive" symptoms (weak stream and hesitancy), only the total scores were reported.1 It would be useful to know the score for each category of symptoms, because the degree of relief of the two types . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.